Management of Children with Optic Gliomas and Neurofibromatosis Type 1

Giorgio Attina'; Palma Maurizi; Silvia Triarico; Michele Antonio Capozza; Alberto Romano; Stefano Mastrangelo; Antonio Ruggiero

doi:10.13005/bpj/2035

Management of Children with Optic Gliomas and Neurofibromatosis Type 1

Giorgio Attina', Palma Maurizi, Silvia Triarico, Michele Antonio Capozza, Alberto Romano, Stefano Mastrangelo, Antonio Ruggiero

Risultato della ricerca: Contributo in rivista › Articolo in rivista › peer review

Abstract

Optic pathway gliomas (OPG) are a common cancer in children with neurofibromatosis type 1.OPGs can cause clinical symptoms such as reduction of visual acuity, alterations of the visual field, pallor of the optical papilla, strabismus, endocrinological alterations up to diencephalic syndrome.The current guidelines provide for wait and see as the main approach if the tumor is not causing visual deterioration and adapting treatment only in the event of significant impairment of the visual function. Therefore, it is essential to early detect the visual deterioration changes as well as the identification of children eligible for treatment. © 2020 This is an Open Access article licensed under a Creative Commons license: Attribution 4.0 International (CC-BY).

Lingua originale	English
pagine (da-a)	1601-1606
Numero di pagine	6
Rivista	BIOMEDICAL & PHARMACOLOGY JOURNAL
Volume	13
DOI	https://doi.org/10.13005/bpj/2035
Stato di pubblicazione	Pubblicato - 2020

Keywords

children
neurofibromatosis type I
optic pathway glioma

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.13005/bpj/2035

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{2c67cda0313742219dc441b3d62bf28b,

title = "Management of Children with Optic Gliomas and Neurofibromatosis Type 1",

abstract = "Optic pathway gliomas (OPG) are a common cancer in children with neurofibromatosis type 1.OPGs can cause clinical symptoms such as reduction of visual acuity, alterations of the visual field, pallor of the optical papilla, strabismus, endocrinological alterations up to diencephalic syndrome.The current guidelines provide for wait and see as the main approach if the tumor is not causing visual deterioration and adapting treatment only in the event of significant impairment of the visual function. Therefore, it is essential to early detect the visual deterioration changes as well as the identification of children eligible for treatment. {\textcopyright} 2020 This is an Open Access article licensed under a Creative Commons license: Attribution 4.0 International (CC-BY).",

keywords = "children, neurofibromatosis type I, optic pathway glioma, children, neurofibromatosis type I, optic pathway glioma",

author = "Giorgio Attina' and Palma Maurizi and Silvia Triarico and Capozza, {Michele Antonio} and Alberto Romano and Stefano Mastrangelo and Antonio Ruggiero",

year = "2020",

doi = "10.13005/bpj/2035",

language = "English",

volume = "13",

pages = "1601--1606",

journal = "BIOMEDICAL & PHARMACOLOGY JOURNAL",

issn = "0974-6242",

publisher = "Bhopal : Oriental Scientific Publishing Co.",

}

TY - JOUR

T1 - Management of Children with Optic Gliomas and Neurofibromatosis Type 1

AU - Attina', Giorgio

AU - Maurizi, Palma

AU - Triarico, Silvia

AU - Capozza, Michele Antonio

AU - Romano, Alberto

AU - Mastrangelo, Stefano

AU - Ruggiero, Antonio

PY - 2020

Y1 - 2020

N2 - Optic pathway gliomas (OPG) are a common cancer in children with neurofibromatosis type 1.OPGs can cause clinical symptoms such as reduction of visual acuity, alterations of the visual field, pallor of the optical papilla, strabismus, endocrinological alterations up to diencephalic syndrome.The current guidelines provide for wait and see as the main approach if the tumor is not causing visual deterioration and adapting treatment only in the event of significant impairment of the visual function. Therefore, it is essential to early detect the visual deterioration changes as well as the identification of children eligible for treatment. © 2020 This is an Open Access article licensed under a Creative Commons license: Attribution 4.0 International (CC-BY).

AB - Optic pathway gliomas (OPG) are a common cancer in children with neurofibromatosis type 1.OPGs can cause clinical symptoms such as reduction of visual acuity, alterations of the visual field, pallor of the optical papilla, strabismus, endocrinological alterations up to diencephalic syndrome.The current guidelines provide for wait and see as the main approach if the tumor is not causing visual deterioration and adapting treatment only in the event of significant impairment of the visual function. Therefore, it is essential to early detect the visual deterioration changes as well as the identification of children eligible for treatment. © 2020 This is an Open Access article licensed under a Creative Commons license: Attribution 4.0 International (CC-BY).

KW - children

KW - neurofibromatosis type I

KW - optic pathway glioma

KW - children

KW - neurofibromatosis type I

KW - optic pathway glioma

UR - http://hdl.handle.net/10807/237016

U2 - 10.13005/bpj/2035

DO - 10.13005/bpj/2035

M3 - Article

SN - 0974-6242

VL - 13

SP - 1601

EP - 1606

JO - BIOMEDICAL & PHARMACOLOGY JOURNAL

JF - BIOMEDICAL & PHARMACOLOGY JOURNAL

ER -

Management of Children with Optic Gliomas and Neurofibromatosis Type 1

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo